باسيليكسيماب
Sign in to saveAlso known as CHI621, SDZ-CHI-621, CHI-621, chimeric mouse-human antiCD25, Ig gamma-1 chain C region
مركب كيميائي
Key facts
- Drug.Verifiedfields
- changed
- Drug.verifiedrevid
- 459525440
- Drug.type
- mab
- Drug.mab_type
- mab
- Drug.source
- xi/o
- Drug.target
- CD25
- Drug.tradename
- Simulect
- Drug.MedlinePlus
- a612013
- Drug.licence_EU
- yes
- Drug.DailyMedID
- Basiliximab
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- Intravenous
- Drug.class
- Immunosuppressants
- Drug.ATC_prefix
- L04
- Drug.ATC_suffix
- AC02
- Drug.legal_US
- Rx-only
- Drug.legal_EU
- Rx-only
- Drug.legal_status
- Rx-only
via Wikipedia infobox
Chemical data
Drug data · ChEMBL
- Max clinical phase
- Approved
- Molecule type
- Antibody
- First approval
- 1998
- Admin. routes
- parenteral
- Indications
- neoplasm, ulcerative colitis, immune system disease, chronic kidney disease
via ChEMBL · EBI
Research
1,835 papers- Basiliximab.Drugs · 1999
- Basiliximab application on liver recipients: a meta-analysis of randomized controlled trials.Hepatobiliary & pancreatic diseases international : HBPD INT · 2017
- Basiliximab: a review of its use as induction therapy in renal transplantation.Drugs · 2003
- Treatment Options in Refractory Autoimmune Encephalitis.CNS drugs · 2022
- Basiliximab or antithymocyte globulin for induction therapy in kidney transplantation: a meta-analysis.Transplantation proceedings · 2010
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Has use
- medication
Show 6 more facts
- defined daily dose
- 40
- World Health Organisation international non-proprietary name
- basiliximab
- subject has role
- monoclonal antibody
- chemical formula
- C₆₃₇₈H₉₈₄₄N₁₆₉₈O₁₉₉₇S₄₈
- has characteristic
- biopharmaceutical
- legal status (medicine)
- boxed warning
Sources (7)
via Wikidata · CC0
Article · العربية
باسيليكسيماب هو جسم مضاد وحيد النسيلة يستخدم لمنع رفض الطعم في حالات زراعة الأعضاء، الكلى خصوصاً، تنتجه نوفارتس. وقد أقرت إدارة الأغذية والأدوية استخدامه عام 1998. بعض التقارير بينت أنه كان فعالاً في علاج حالات حزاز جلدي بديلاً عن سيكلوسبورين.
Abstract from DBpedia / Wikipedia · CC BY-SA